Pro-Osteogenic and Anti-Inflammatory Synergistic Effect of Orthosilicic Acid, Vitamin K2, Curcumin, Polydatin and Quercetin Combination in Young and Senescent Bone Marrow-Derived Mesenchymal Stromal Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 May 27

PMID 37240169

Authors

Chiara Giordani

Giulia Matacchione

Angelica Giuliani

Debora Valli

Emanuele Salvatore Scarpa

Antonella Antonelli

Jacopo Sabbatinelli

Gilberta Giacchetti

Sofia Sabatelli

Fabiola Olivieri

Maria Rita Rippo

Affiliations

Soon will be listed here.

Abstract

During aging, bone marrow mesenchymal stromal cells (MSCs)-the precursors of osteoblasts-undergo cellular senescence, losing their osteogenic potential and acquiring a pro-inflammatory secretory phenotype. These dysfunctions cause bone loss and lead to osteoporosis. Prevention and intervention at an early stage of bone loss are important, and naturally active compounds could represent a valid help in addition to diet. Here, we tested the hypothesis that the combination of two pro-osteogenic factors, namely orthosilicic acid (OA) and vitamin K2 (VK2), and three other anti-inflammatory compounds, namely curcumin (CUR), polydatin (PD) and quercetin (QCT)-that mirror the nutraceutical BlastiMin Complex (Mivell, Italy)-would be effective in promoting MSC osteogenesis, even of replicative senescent cells (sMSCs), and inhibiting their pro-inflammatory phenotype in vitro. Results showed that when used at non-cytotoxic doses, (i) the association of OA and VK2 promoted MSC differentiation into osteoblasts, even when cultured without other pro-differentiating factors; and (ii) CUR, PD and QCT exerted an anti-inflammatory effect on sMSCs, and also synergized with OA and VK2 in promoting the expression of the pivotal osteogenic marker ALP in these cells. Overall, these data suggest a potential role of using a combination of all of these natural compounds as a supplement to prevent or control the progression of age-related osteoporosis.

Citing Articles

Management of Fibromyalgia: Novel Nutraceutical Therapies Beyond Traditional Pharmaceuticals.

Antonelli A, Bianchi M, Fear E, Giorgi L, Rossi L Nutrients. 2025; 17(3).

PMID: 39940388 PMC: 11820827. DOI: 10.3390/nu17030530.

A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability.

Frent O, Stefan L, Morgovan C, Duteanu N, Dejeu I, Marian E Int J Mol Sci. 2024; 25(22).

PMID: 39596162 PMC: 11594109. DOI: 10.3390/ijms252212091.

Cellular Senescence: The Driving Force of Musculoskeletal Diseases.

Falvino A, Gasperini B, Cariati I, Bonanni R, Chiavoghilefu A, Gasbarra E Biomedicines. 2024; 12(9).

PMID: 39335461 PMC: 11429507. DOI: 10.3390/biomedicines12091948.

Pro-Osteogenic Effect of the Nutraceutical BlastiMin Complex in Women with Osteoporosis or Osteopenia: An Open Intervention Clinical Trial.

Sabatelli S, Scarpa E, Giuliani A, Giordani C, Sabbatinelli J, Rippo M Int J Mol Sci. 2024; 25(16).

PMID: 39201253 PMC: 11354786. DOI: 10.3390/ijms25168565.

Anti-Inflammatory and Antioxidant Properties of a New Mixture of Vitamin C, Collagen Peptides, Resveratrol, and Astaxanthin in Tenocytes: Molecular Basis for Future Applications in Tendinopathies.

Marzagalli M, Battaglia S, Raimondi M, Fontana F, Cozzi M, Ranieri F Mediators Inflamm. 2024; 2024:5273198.

PMID: 39108992 PMC: 11303056. DOI: 10.1155/2024/5273198.

References

Wong S, Chin K, Ima-Nirwana S . Quercetin as an Agent for Protecting the Bone: A Review of the Current Evidence. Int J Mol Sci. 2020; 21(17). PMC: 7503351. DOI: 10.3390/ijms21176448. View

Zhao B, Zhao W, Wang Y, Zhao Z, Zhao C, Wang S . Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization. PLoS One. 2018; 13(8):e0202269. PMC: 6101397. DOI: 10.1371/journal.pone.0202269. View

. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021; 28(9):973-997. DOI: 10.1097/GME.0000000000001831. View

Foger-Samwald U, Kerschan-Schindl K, Butylina M, Pietschmann P . Age Related Osteoporosis: Targeting Cellular Senescence. Int J Mol Sci. 2022; 23(5). PMC: 8910503. DOI: 10.3390/ijms23052701. View

Bielak-Zmijewska A, Grabowska W, Ciolko A, Bojko A, Mosieniak G, Bijoch L . The Role of Curcumin in the Modulation of Ageing. Int J Mol Sci. 2019; 20(5). PMC: 6429134. DOI: 10.3390/ijms20051239. View

Farr J, Rowsey J, Eckhardt B, Thicke B, Fraser D, Tchkonia T . Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans. J Bone Miner Res. 2019; 34(8):1407-1418. PMC: 6697189. DOI: 10.1002/jbmr.3729. View

Matacchione G, Valli D, Silvestrini A, Giuliani A, Sabbatinelli J, Giordani C . Curcumin, Polydatin and Quercetin Synergistic Activity Protects from High-Glucose-Induced Inflammation and Oxidative Stress. Antioxidants (Basel). 2022; 11(6). PMC: 9220232. DOI: 10.3390/antiox11061037. View

Zhu K, Prince R . Lifestyle and osteoporosis. Curr Osteoporos Rep. 2014; 13(1):52-9. DOI: 10.1007/s11914-014-0248-6. View

Ji M, Yu Q . Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med. 2017; 1(1):9-13. PMC: 5643776. DOI: 10.1016/j.cdtm.2015.02.006. View

10.

Feng X, McDonald J . Disorders of bone remodeling. Annu Rev Pathol. 2010; 6:121-45. PMC: 3571087. DOI: 10.1146/annurev-pathol-011110-130203. View

11.

Pignolo R, Law S, Chandra A . Bone Aging, Cellular Senescence, and Osteoporosis. JBMR Plus. 2021; 5(4):e10488. PMC: 8046105. DOI: 10.1002/jbm4.10488. View

12.

Liu Q, Guo Y, Wang Y, Zou X, Yan Z . miR‑98‑5p promotes osteoblast differentiation in MC3T3‑E1 cells by targeting CKIP‑1. Mol Med Rep. 2018; 17(3):4797-4802. DOI: 10.3892/mmr.2018.8416. View

13.

Olivieri F, Prattichizzo F, Giuliani A, Matacchione G, Rippo M, Sabbatinelli J . miR-21 and miR-146a: The microRNAs of inflammaging and age-related diseases. Ageing Res Rev. 2021; 70:101374. DOI: 10.1016/j.arr.2021.101374. View

14.

Li Y, Wang J, Chen G, Feng S, Wang P, Zhu X . Quercetin promotes the osteogenic differentiation of rat mesenchymal stem cells via mitogen-activated protein kinase signaling. Exp Ther Med. 2015; 9(6):2072-2080. PMC: 4473649. DOI: 10.3892/etm.2015.2388. View

15.

Weiskirchen S, Weiskirchen R . Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy?. Adv Nutr. 2016; 7(4):706-18. PMC: 4942868. DOI: 10.3945/an.115.011627. View

16.

David K, Narinx N, Antonio L, Evenepoel P, Claessens F, Decallonne B . Bone health in ageing men. Rev Endocr Metab Disord. 2022; 23(6):1173-1208. DOI: 10.1007/s11154-022-09738-5. View

17.

Gurau F, Baldoni S, Prattichizzo F, Espinosa E, Amenta F, Procopio A . Anti-senescence compounds: A potential nutraceutical approach to healthy aging. Ageing Res Rev. 2018; 46:14-31. DOI: 10.1016/j.arr.2018.05.001. View

18.

Lane N . Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006; 194(2 Suppl):S3-11. DOI: 10.1016/j.ajog.2005.08.047. View

19.

Cawthon R . Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30(10):e47. PMC: 115301. DOI: 10.1093/nar/30.10.e47. View

20.

Zhou H, Jiao G, Dong M, Chi H, Wang H, Wu W . Orthosilicic Acid Accelerates Bone Formation in Human Osteoblast-Like Cells Through the PI3K-Akt-mTOR Pathway. Biol Trace Elem Res. 2018; 190(2):327-335. DOI: 10.1007/s12011-018-1574-9. View